|
| Tuesday, March 25, 2025 |
|
|
NTT, DOCOMO and NEC Demonstrate World's Fastest 140 Gbps Bidirectional Wireless Transmission in 80 GHz Band |
| NTT Corporation, NTT DOCOMO, INC. and NEC Corporation announced today that they demonstrated a real-time bidirectional wireless transmission in the millimeter wave band between 71 GHz and 86 GHz that achieved a bit rate of 140 Gbps --- unprecedented for sub-100 GHz frequencies. more info >> |
|
| Monday, March 10, 2025 |
|
|
CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC's AI |
| NEC Corporation (NEC; TSE: 6701) has announced that it will partner with the Nagasaki University DEJIMA Infectious Disease Research Alliance (Director: Prof. Kouichi Morita) for a research and development (R&D) project with support from the Coalition for Epidemic Preparedness Innovations (CEPI). more info >> |
|
| Thursday, March 6, 2025 |
|
|
NEC improves the energy efficiency and floor space density of 5G Mobile Core systems |
| NEC Corporation has improved the performance-to-power ratio of 5G mobile core systems (5GC) by more than 6 times, as well as floor space density by 10 times. more info >> |
|
| Thursday, February 1, 2024 |
|
|
NEC joins Columbia University-led National Science Foundation Engineering Research Center for Smart Streetscapes (CS3) |
| NEC Corporation has concluded a membership agreement with the U.S.-based National Science Foundation Engineering Research Center for Smart Streetscapes (CS3), a Columbia University-led initiative supporting the development of a rich ecosystem of streetscape applications. more info >> |
|
| Friday, January 26, 2024 |
|
|
NEC Showcases AI Technologies and Networking Strengths at MWC Barcelona 2024 |
| NEC Corporation (NEC; TSE: 6701) announced today that it will showcase its latest digital transformation capabilities, including a wide range of AI and global network technologies, at MWC Barcelona 2024 from February 26 - 29 at Hall 2, Stand 2H40. more info >> |
|
| Thursday, January 25, 2024 |
|
|
NEC receives order for KIOSK enabling one-stop immigration and customs declaration procedures at Haneda Airport Terminal 2 |
| NEC Corporation today announced that it has received an order from the Immigration Services Agency and Japan Customs for the installation of Immigration & Customs Declaration KIOSKs that will be jointly used for immigration and customs inspections to facilitate seamless immigration and customs procedures at Haneda Airport Terminal 2, as well as the design of related systems. more info >> |
|
| Wednesday, January 17, 2024 |
|
|
NEC, Kimuraya and ABEMA use AI to develop bread with a "taste of love" |
| NEC Corporation, together with Kimuraya Sohonten Co., a long-established bread maker, and Abema TV, a video streaming service, have teamed up to produce bread with flavors inspired by the romantic Japanese television program, "I Fell in Love with you Today." more info >> |
|
| Friday, January 12, 2024 |
|
|
NEC Wins Telecom Review Excellence Award for Most Innovative Product/Service Globally for Telco B2B Leadership |
| NEC Corporation (TSE: 6701), a leading global IT and network transformation services provider, today announced that the company has been named winner of the Most Innovative Product/Service (Vendor) - Global award at the Telecom Review Leaders' Summit 2023. more info >> |
|
|
NEC Completes Submarine Cable System for India's BSNL Connecting Kochi and the Lakshadweep Islands |
| NEC Corporation India (NEC India) together with NEC Corporation today announced the successful completion of a flagship optical submarine cable system in Southern India connecting Kochi and the Lakshadweep Islands. more info >> |
|
| Tuesday, January 9, 2024 |
|
|
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050 |
| Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, have announced the signing of a further development collaboration agreement to continue the clinical evaluation of the individualized neoantigen cancer vaccine TG4050. more info >> |
|
|
|
|
